---
$id: https://graph.org.ai/products/commodity/51141563
$type: Product
source: UNSPSC
code: "51141563"
title: "Lacosamide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lacosamide

**UNSPSC Code**: 51141563
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C13H18N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 563KS2PQY5, chemically known as 2-(acetylamino)-3-methoxy-n-(phenylmethyl)propanamide, (2r)- but generally known as lacosamide, which bears US NIH Compound Identifier 219078. European Medicines Agency schedules Lacosamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25407. The term LACOSAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, No. 3, 2004, List 52). World Health Organization schedules lacosamide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule lacosamide under HS 29242995 and SITC 51479. As of Q4 2014, LACOSAMIDE remains the US FDA Preferred Term for this commodity. Lacosamide bears US NLM identifiers UMLS ID C1311230 and NCI Concept Code C83859. SMILES: O(CC(NC(=O)C)C(=O)NCC1CCCCC1)C.

